Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The not-so-simple HDL story

Is it time to revise the HDL cholesterol hypothesis?

Formation of plaques in artery walls, or atherogenesis, is known to lead to cardiovascular disease risk and heart disease. Low-density lipoproteins (LDLs), which deliver cholesterol to inflammatory cells in blood vessels, are linked to disease, which is commonly managed using cholesterol-lowering therapies. Whether increasing levels of high-density lipoproteins (HDLs), which remove cholesterol from the circulation, can be cardioprotective has not been clear, despite early clinical studies showing evidence for a positive effect in cardiovascular disease. In 'Bench to Bedside', Daniel J. Rader and Alan R. Tall discuss how the field should focus on promoting reverse cholesterol transport that would result in cholesterol efflux from macrophages to biliary excretion rather than simply trying to increase HDL cholesterol levels. Understanding how different molecular mechanisms operate in this 'HDL flux hypothesis' will uncover ways to develop HDL-targeted therapeutics that will protect from cardiovascular and heart disease. In 'Bedside to Bench', Jay W. Heinecke peruses clinical studies to propose better and simpler ways to measure reverse cholesterol transport in the clinic. Genetic alterations and factors involved in HDL functionality may be useful for quantifying HDL function and finding effective drugs to lower cardiovascular disease risk.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Pathways influencing HDL cholesterol metabolism and flux and potential relationship to atherosclerosis.

References

  1. Rader, D.J., Alexander, E.T., Weibel, G.L., Billheimer, J. & Rothblat, G.H. J. Lipid Res. 50 Suppl, S189–S194 (2009).

    Article  Google Scholar 

  2. Murphy, A.J., Westerterp, M., Yvan-Charvet, L. & Tall, A.R. Biochim. Biophys. Acta 1821, 513–521 (2012).

    Article  CAS  Google Scholar 

  3. Zhang, Y. et al. Circulation 108, 661–663 (2003).

    Article  CAS  Google Scholar 

  4. Nissen, S.E. et al. J. Am. Med. Assoc. 290, 2292–2300 (2003).

    Article  CAS  Google Scholar 

  5. Wang, X. et al. J. Clin. Invest. 117, 2216–2224 (2007).

    Article  CAS  Google Scholar 

  6. Yvan-Charvet, L. et al. J. Clin. Invest. 117, 3900–3908 (2007).

    CAS  Google Scholar 

  7. Naik, S.U. et al. Circulation 113, 90–97 (2006).

    Article  CAS  Google Scholar 

  8. Rayner, K.J. et al. J. Clin. Invest. 121, 2921–2931 (2011).

    Article  CAS  Google Scholar 

  9. Yvan-Charvet, L. et al. Science 328, 1689–1693 (2010).

    Article  CAS  Google Scholar 

  10. Westerterp, M. et al. Cell Stem Cell 11, 195–206 (2012).

    Article  CAS  Google Scholar 

  11. Dutta, P. et al. Nature 487, 325–329 (2012).

    Article  CAS  Google Scholar 

  12. AIM-HIGH Investigators et al. N. Engl. J. Med. 365, 2255–2267 (2011).

  13. Schwartz, G.G. et al. Am. Heart J. 158, 896–901 (2009).

    Article  CAS  Google Scholar 

  14. Voight, B.F. et al. Lancet 380, 572–580 (2012).

    Article  CAS  Google Scholar 

  15. Nordestgaard, B.G., Benn, M., Schnohr, P. & Tybjaerg-Hansen, A. J. Am. Med. Assoc. 298, 299–308 (2007).

    Article  CAS  Google Scholar 

  16. Yvan-Charvet, L. et al. Arterioscler. Thromb. Vasc. Biol. 30, 1430–1438 (2010).

    Article  CAS  Google Scholar 

  17. Khera, A.V. et al. N. Engl. J. Med. 364, 127–135 (2011).

    Article  CAS  Google Scholar 

  18. Steinberg, D. J. Lipid Res. 47, 1339–1351 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Daniel J Rader or Alan R Tall.

Ethics declarations

Competing interests

A.R.T. is a consultant for Merck, Pfizer, Roche, Amgen, CSL and Arisaph and receives research support from CSL.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rader, D., Tall, A. Is it time to revise the HDL cholesterol hypothesis?. Nat Med 18, 1344–1346 (2012). https://doi.org/10.1038/nm.2937

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2937

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing